Skip to main content
Top
Literature
2.
go back to reference Bandak G, Sang Y, Gasparini A et al (2017) Hyperkalemia after initiating renin–angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project. J Am Heart Assoc 6:e005428CrossRefPubMedPubMedCentral Bandak G, Sang Y, Gasparini A et al (2017) Hyperkalemia after initiating renin–angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project. J Am Heart Assoc 6:e005428CrossRefPubMedPubMedCentral
3.
go back to reference Sousa AGP, de Sousa Cabral JV, El-Feghaly WB, de Sousa LS, Nunes AB (2016) Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes 7:101CrossRefPubMedPubMedCentral Sousa AGP, de Sousa Cabral JV, El-Feghaly WB, de Sousa LS, Nunes AB (2016) Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes 7:101CrossRefPubMedPubMedCentral
5.
go back to reference Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C (2015) Drug-induced hyperglycaemia and diabetes. Drug Saf 38:1153–1168CrossRefPubMed Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C (2015) Drug-induced hyperglycaemia and diabetes. Drug Saf 38:1153–1168CrossRefPubMed
Metadata
Title
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment
Authors
Murat Özdede
Alper Tuna Güven
Publication date
03-01-2024
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 3/2024
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-023-03520-4

Other articles of this Issue 3/2024

Internal and Emergency Medicine 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.